title: Meeting requirements for primate animals in drug development.
abstract: An overview on the numbers and species of monkeys used in the area of drug development in the USA and Europe during the years 1975 to 1981 is presented. A marked decline of 25% to 40% in the numbers used is due to a more critical use of the various species, besides a shortage of available animals. However, because for certain experiments some primate species are the animals of choice, there is a limit to further reductions. For future supplies, intensive breeding units, semifree-range colonies, and game farming may be considered. Using the revenue of exported animals, a financial contribution to the conservation of feral animals in the countries of origin could be made.
mesh_terms: D000822:Animal Husbandry / Q000592:standards*; D000827:Animal Welfare / Q000592:standards; D000818:Animals; D000830:Animals, Laboratory; D000882:Haplorhini; D004364:Pharmaceutical Preparations; D011323:Primates; D012106:Research / Q000592:standards*
chemical_list: D004364:Pharmaceutical Preparations